A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic Surgery
Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Oct 16, 2024
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Endoscopic surgery is the most important and commonly used minimally invasive surgery technology in the field of modern surgery, especially in hepatobiliary surgery, which has become one of the conventional diagnosis and treatment methods of surgery. Compared with traditional open surgery, it has smaller trauma, faster recovery time and lower complication rate. However, the limited visual field of surgical observation caused by the narrow surgical space and the difficulty of immediate identification of key events in the surgical scene greatly increase the difficulty and complexity of endosc...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Voluntarily sign informed consent Patients who underwent hepatectomy and cholecystectomy and were followed up in the research center hospitals from July 2024 to December 2028 Complete case, imaging and operation video data
- Exclusion Criteria:
- • Patients who had other diseases before surgery, which may affect the results of the study Patients who developed postoperative complications but could not confirm their relevance to surgery According to the judgment of the researcher, it is not suitable to participate in this study
About Nanfang Hospital, Southern Medical University
Nanfang Hospital, affiliated with Southern Medical University, is a leading medical institution in China renowned for its comprehensive clinical services and commitment to advancing healthcare through research and education. As a clinical trial sponsor, Nanfang Hospital leverages its state-of-the-art facilities and a multidisciplinary team of expert researchers to conduct innovative studies aimed at improving patient outcomes and contributing to the global medical community. The hospital's focus on ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and scientific rigor.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Kai Wang
Principal Investigator
Department of hepatobiliary surgery, Nanfang Hospital, Southern Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported